Goldman v. Brain Tunnelgenix Technologies Corp.

CourtDistrict Court, S.D. Florida
DecidedJune 13, 2024
Docket1:23-cv-24352
StatusUnknown

This text of Goldman v. Brain Tunnelgenix Technologies Corp. (Goldman v. Brain Tunnelgenix Technologies Corp.) is published on Counsel Stack Legal Research, covering District Court, S.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Goldman v. Brain Tunnelgenix Technologies Corp., (S.D. Fla. 2024).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF FLORIDA

Case No. 23-cv-24352-BLOOM/Torres

ROBERT M. GOLDMAN, an individual, and RONALD M. KLATZ, an individual,

Plaintiffs,

v.

BRAIN TUNNELGENIX TECHNOLOGIES, CORP., and MARCIO AURELLO MARTINS ABREU a/k/a M. MARC ABREU, an individual,

Defendants. ______________________________________________/

ORDER ON MOTION TO DISMISS

THIS CAUSE is before the Court upon Defendant Brain Tunnelgenix Technologies Corporation (“BTT”) and Defendant Dr. Marcio Marc Aurello Martins Abreu’s (“Abreu”) (together “Defendants”) Motion to Dismiss the Complaint, (“Motion to Dismiss”). ECF No. [16]. Plaintiffs Dr. Robert M. Goldman (“Goldman”) and Dr. Ronald M. Klatz (“Klatz”), (together “Plaintiffs”) filed a Response, ECF No. [23], and Defendants filed a Reply, ECF No. [28]. The Court has reviewed the Motion to Dismiss, the supporting and opposing submissions, the record, and is otherwise fully advised. For the reasons that follow, Defendants’ Motion to Dismiss is granted. I. BACKGROUND Plaintiffs brought an action for damages against Defendants relating to a March 2016 purchase of 76,923 shares in BTT by Plaintiffs’ company, MDM Consultants, Inc. (“MDM”). Plaintiffs allege that Abreu violated securities laws in the sale of the shares, specifically the Securities Act of 1934 § 10(b), 15 U.S.C. § 78a, et seq. as promulgated under 17 C.F.R. § 240.10b- 5 (“Rule 10b-5”). See ECF No. [1] at 14. Plaintiffs also claim their $500,000.00 investment was converted by Defendants who were unjustly enriched in the process. Id. at 15-16. Plaintiffs allege that Abreu deceived them as they do not typically invest in companies solely as equity investors, they finally agreed to invest in BTT having relied on Abreu’s representations that BTT was

thriving, and Abreu would find a compensated role for them within BTT. Id. ¶¶ 20-23. The Parties were in a business relationship that spanned six years, during which time Plaintiffs allege they provided “extraordinary services” by introducing Abreu to various technologies, exposure to their medical know-how, allowed Abreu to feature them as advisors, and by securing prominent speaking engagements for Abreu. Id. ¶¶ 28-32. However, after repeated requests, Plaintiffs claim they were never paid for their consulting services despite contributing significantly to the value of BTT. The Complaint asserts three counts against both Defendants: Count I: Violation of Section 10(B) of the Securities Exchange Act and Rule 10b- 5; Count II: Conversion of their $500,000.00 investment in BTT; and Count III: Unjust enrichment for their $500,000.00 investment in BTT.

ECF No. [1] at 14-16. Defendants move to dismiss the Complaint on three bases: (1) Plaintiffs lack standing; (2) the federal securities claims are time barred by the statute of repose; and (3) Plaintiffs fail to state valid claims. ECF No. [16] at 1. Defendants argue that if Count I is dismissed, this Court will lack subject matter jurisdiction over Plaintiffs’ state law claims for conversion and unjust enrichment. ECF No. [16] at 17. Defendants also assert this action was filed because Plaintiffs’ demand for a portion of BTT was rejected. Id. at 1. Plaintiffs’ counsel sent Defendants’ counsel a letter on April 18, 2023, indicating Plaintiffs’ contributions as advisors to BTT have a fair market value of between five to ten percent of the company. ECF No. [1-1] at 3. Following an April 2022 investment, it is alleged that BTT reached a valuation of $1.7 billion. ECF No. [1] ¶ 41; ECF No. [1-1] at 3. Consequently, Plaintiffs’ demand was $85,000,000.00 at the low end of their assessed fair market value for their advisory services to BTT. Id. Plaintiffs respond that the misrepresentations leading up to the purchase of the shares is a violation of securities law and takes aim at Defendants’ argument that the Rule 10b-5 claim is time

barred. The alleged misrepresentations include statements by Abreu that Bill Gates and Google were interested in purchasing BTT, that BTT was soon to launch various products, that there was a planned IPO for BTT within three years, and that Abreu intended to make Plaintiffs paid consultants. ECF No. [23] at 5. Further, Plaintiffs argue that their state law claims are valid and well-pled. Plaintiffs assert that their unjust enrichment claim can be pled in the alternative to a contractual right to the shares because their claim is based on fraud, not an express contract. Id. at 6-7. Plaintiffs argue Defendants claimed that they owed $1,923,076.00 for the shares in an August 2023 communication to them, which was an attempt to divest them of the shares, and therefore conversion are well pled. ECF No. [1] ¶ 51; ECF No. [23] at 37. Finally, Plaintiffs argue that because MDM is wholly owned by Plaintiffs who are the only two principals of MDM, they have

standing and will amend the complaint to add MDM if necessary. ECF No. [23] at 28. Defendants reply that Plaintiffs conceded that they lack standing. ECF No. [28] at 2. Defendants also argue that granting leave to amend the Complaint to add MDM as a Plaintiff would be futile based on the statute of repose that would still apply to the sole purchase date of the shares. Regarding the state law claims in Counts II and III, Defendants urge that this Court decline to exercise supplemental jurisdiction should Count I be dismissed. II. LEGAL STANDARD A. Motion to Dismiss When reviewing a motion to dismiss, a court, as a general rule, must accept the plaintiff’s allegations as true and evaluate all plausible inferences derived from those facts in favor of the plaintiff. See Chaparro v. Carnival Corp., 693 F.3d 1333, 1337 (11th Cir. 2012); Miccosukee Tribe of Indians of Fla. v. S. Everglades Restoration Alliance, 304 F.3d 1076, 1084 (11th Cir. 2002); AXA Equitable Life Ins. Co. v. Infinity Fin. Grp., LLC, 608 F. Supp. 2d 1349, 1353 (S.D. Fla. 2009) (“On a motion to dismiss, the complaint is construed in the light most favorable to the non-moving

party, and all facts alleged by the non-moving party are accepted as true.”); Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009). “Where a defendant seeking dismissal of a complaint under Rule 12(b)(6) does not provide legal authority in support of its arguments, it has failed to satisfy its burden of establishing its entitlement to dismissal.” Sprint Sols., Inc., v. Fils-Amie, 44 F. Supp. 3d 1224, 1228 (S.D. Fla. Sept. 12, 2014) (citing Super. Energy Servs., LLC v. Boconco, Inc., No. 09-0321, 2010 WL 1267173, at *5-6 (S.D. Ala. Mar. 26, 2010) and United States v. Vernon, 108 F.R.D. 741, 742 (S.D. Fla. Jan. 7, 1986)). B. Futility of Amendment District courts “have broad discretion in permitting or refusing to grant leave to amend.” Garfield v. NDC Health Corp., 466 F.3d 1255, 1270 (11th Cir. 2006) (quoting Foman v. Davis,

371 U.S. 178, 182 (1962)). The Federal Rules of Civil Procedure

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Meredith T. Raney, Jr. v. Allstate Insurance Co.
370 F.3d 1086 (Eleventh Circuit, 2004)
Robert Garfield v. NDCHealth Corporation
466 F.3d 1255 (Eleventh Circuit, 2006)
Cockrell v. Sparks
510 F.3d 1307 (Eleventh Circuit, 2007)
Foman v. Davis
371 U.S. 178 (Supreme Court, 1962)
Blue Chip Stamps v. Manor Drug Stores
421 U.S. 723 (Supreme Court, 1975)
Securities & Exchange Commission v. Zandford
535 U.S. 813 (Supreme Court, 2002)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Berk v. MARYLAND PUBLICK BANKS, INC.
6 F. Supp. 2d 472 (D. Maryland, 1998)
Allen Licht v. Ajene Watson
567 F. App'x 689 (Eleventh Circuit, 2014)
Resolution Trust Corp. v. Dunmar Corp.
43 F.3d 587 (Eleventh Circuit, 1995)
Sprint Solutions, Inc. v. Fils-Amie
44 F. Supp. 3d 1224 (S.D. Florida, 2014)
Melford v. Kahane & Assocs.
371 F. Supp. 3d 1116 (S.D. Florida, 2019)
Chaparro v. Carnival Corp.
693 F.3d 1333 (Eleventh Circuit, 2012)
Axa Equitable Life Insurance v. Infinity Financial Group, LLC
608 F. Supp. 2d 1349 (S.D. Florida, 2009)
Delta Coal Program v. Libman
743 F.2d 852 (Eleventh Circuit, 1984)
United States v. Vernon
108 F.R.D. 741 (S.D. Florida, 1986)

Cite This Page — Counsel Stack

Bluebook (online)
Goldman v. Brain Tunnelgenix Technologies Corp., Counsel Stack Legal Research, https://law.counselstack.com/opinion/goldman-v-brain-tunnelgenix-technologies-corp-flsd-2024.